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Summary 
Tightly orchestrated gene expression programs enable proper neuronal development 
as well as the synaptic adaptations that are responsible for learning and memory 
processes. MicroRNAs (miRNAs) are a class of short regulatory RNA molecules which 
negatively affect the translation of target mRNAs, thereby contributing to the regulation 
of gene expression during brain development and cognitive functions. 
In the present cumulative thesis, I summarize my contributions to three research 
articles which describe the impact of specific miRNAs and an upstream regulator, the 
nuclear receptor co-activator 3 (Ncoa3), on neuronal growth and synaptic function. 
In the first publication, we identified miR-181a to be enriched at synaptic sites of the 
nucleus accumbens, a brain region of the dopaminergic mesolimbic system which is 
involved in the development of addiction. Using primary neurons, we demonstrated that 
miR-181a directly regulates the expression of the AMPA-receptor (AMPA-R) subunit 
GluA2. Neuromorphological analysis and electrophysiological measurements showed 
that miR-181a affects transmission at excitatory synapses. Dopamine signaling 
stimulated the expression of miR-181a which further influenced the dopamine-
dependent control of GluA2 expression. Treatment of mice with several drugs of abuse 
specifically upregulated miR-181a levels in different brain regions. Taken together, this 
publication established miR-181a as novel regulator of synaptic efficacy and in the 
context of the present literature as a potential modulator of addiction behavior. 
Based on previous findings that showed the synaptic localization of miR-137 and that 
identified mutations in the MIR137 gene associated with schizophrenia and cognitive 
disabilities, we investigated the postsynaptic functions of miR-137 in the second 
publication. Manipulations of miR-137 expression provided evidence that the AMPA-R 
subunit GluA1 mRNA is a direct target of miR-137. Intriguingly, morphological and 
electrophysiological measurements revealed that miR-137 regulates the number but 
not the strength of excitatory synapses. MiR-137 further promoted the formation of 
silent synapses, since miR-137 manipulations affected AMPA-R-, but not NMDA-
receptor (NMDA-R)-dependent currents. Furthermore, induction of miR-137 expression 
was required for mGluR-dependent long term depression (LTD). Therefore, this 
research article provides experimental support for a postsynaptic function of miR-137 
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in the regulation of synapse formation and plasticity, with possible implications for 
schizophrenia and cognitive disabilities. 
In the third publication, which includes the main part of my PhD project, 10 novel 
regulators of miRNA-dependent gene silencing in neurons were identified by 
performing an RNAi-based screen. One of the newly ascertained proteins was Ncoa3, 
a transcription co-activator whose function in hippocampal neurons was not studied. 
Reporter gene assays showed that Ncoa3 was required for miRNA-mediated 
repression of a specific set of miRNA target genes, including Limk1. In addition, Ncoa3-
knockdown increased endogenous Limk1 protein levels and interfered with miR-134-
induced spine shrinkage. At the same time, Ncoa3 deficiency by itself reduced the size 
of dendritic spines and the amplitude of miniature excitatory postsynaptic currents 
(mEPSCs) while it stimulated dendrite growth. The latter phenotype was dependent on 
proper miRNA-expression. Ago2 is a central effector of miRNA repression and we 
established it further as a direct transcriptional target gene of Ncoa3. Epistasis 
experiments confirmed that both impaired dendritogenesis and miRNA function upon 
Ncoa3 knockdown were a result of reduced Ago2 expression. Thus, this publication 
uncovered a novel transcriptional mechanism for the control of miRNA-dependent 
repression during neuronal development. 
In summary, these findings decipher neuronal gene expression programs which control 
synaptic adaptations and thus are potentially involved in learning and memory 
processes. 
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Zusammenfassung 
Präzise koordinierte Genexpressionsprogramme ermöglichen korrekte neuronale 
Entwicklung und synaptische Anpassungen, die für Lern- und Gedächtnisprozesse 
verantwortlich sind. MicroRNAs (miRNAs) sind eine Klasse kurzer regulatorischer 
RNA-Moleküle, welche die Translation von spezifischen Ziel-mRNAs unterdrücken und 
dadurch zur Regulation der Genexpression während der Entwicklung des Gehirns und 
kognitiver Fähigkeiten beitragen. 
In der vorliegenden kumulativen Dissertation fasse ich meinen Beitrag zu drei 
Forschungsartikeln zusammen. Sie beschreiben den Einfluss von bestimmten 
miRNAs, sowie eines vorgeschalteten Regulators (Nuclear receptor co-activator 3 
(Ncoa3)) auf neuronales Wachstum und synaptische Funktion. 
In der ersten Veröffentlichung entdecken wir eine Anreicherung von miR-181a an 
Synapsen des Nucleus Accumbens, einer Hirnregion des dopaminergen 
mesolimbischen Systems, die an der Entwicklung von Suchterkrankungen beteiligt ist. 
Mittels primärer Neuronen wiesen wir nach, dass miR-181a die Expression der AMPA-
Rezeptor(AMPA-R)-Untereinheit GluA2 direkt reguliert. Neuromorphologische 
Analysen und elektrophysiologische Messungen zeigten zudem, dass miR-181a die 
Reizübertragung an exzitatorischen Synapsen beeinflusst. Aktivierung des Dopamin-
Signalwegs stimulierte die Expression von miR-181a, was sich wiederum auf die 
Dopamin-abhängige Kontrolle der GluA2 Expression auswirkte. Die Gabe von 
unterschiedlichen psychoaktiven Substanzen führte bei Mäusen ebenfalls zu einer 
spezifischen Erhöhung der miR-181a Expression in verschiedenen Hirnregionen. 
Zusammengefasst etabliert diese Veröffentlichung miR-181a als neuen Regulator von 
synaptischer Übertragung und im Kontext aktueller Literatur als potentiellen Modulator 
von Suchtverhalten. 
Basierend auf früheren Befunden, welche die synaptische Lokalisierung von miR-137 
zeigten, und eine Assoziation von Mutationen im MIR137 Gen mit Schizophrenie und 
geistiger Behinderung identifizierten, untersuchten wir in der zweiten Veröffentlichung 
die postsynaptische Funktion von miR-137. Einflussnahme auf die miR-137 
Expressionslevels belegte, dass die AMPA-R-Untereinheit GluA1 mRNA ein direktes 
Ziel von miR-137 ist. Interessanterweise zeigten morphologische und 
elektrophysiologische Messungen, dass miR-137 nur die Anzahl, nicht jedoch die 
Zusammenfassung 
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Stärke von exzitatorischen Synapsen reguliert. Ferner begünstigte miR-137 die Bildung 
von stummen Synapsen, da veränderte miR-137 Expression zwar AMPA-R-
abhängige, nicht jedoch NMDA-Rezeptor(NMDA-R)-abhängige Ströme beeinflusste. 
Außerdem war der Anstieg von miR-137 notwendig für mGluR-abhängige Langzeit-
Depression (LTD). Diese Publikation untermauert somit eine postsynaptische Funktion 
von miR-137 in der Regulation von Synapsenbildung und –plastizität, sowie eine damit 
verbundene mögliche Bedeutung für Schizophrenie und geistige Behinderung.  
In der dritten Veröffentlichung, die den Hauptteil meiner Doktorarbeit beinhaltet, wurden 
mittels einem RNAi-basierten Screen zehn neue Regulatoren der miRNA-abhängiger 
Geneexpressionshemmung in Neuronen identifiziert. Eines der neu ermittelten 
Proteine war Ncoa3, ein Transkriptionscoaktivator dessen Funktion in Hippocampus-
Neuronen bislang noch nicht untersucht war. Reportergen-Assays zeigten, dass Ncoa3 
für miRNA-vermittelte Repression bei einer spezifischen Gruppe von miRNA-
Zielgenen, inklusive Limk1, erforderlich ist. Zusätzlich hatte Ncoa3-knockdown zur 
Folge, dass endogene Limk1 Proteinmengen erhöht waren, und dass das miR-134-
induzierte Schrumpfen von dendritischen Dornfortsätzen gestört war. Alleinige Ncoa3-
Defizienz war zudem ausreichend die Größe von dendritischen Dornfortsätzen und die 
Amplitude von Miniatur exzitatorischen postsynaptischen Strömen (mEPSCs) zu 
reduzieren, während sie das Dendritenwachstum stimulierte. Dieser letztere Phänotyp 
war abhängig von ordnungsgemäßer miRNA-Expression. Ago2 ist ein zentraler 
Effektor von miRNA-Repression und wir etablierten es ferner als direktes 
transkriptionelles Zielgen von Ncoa3. Epistase-Experimente bestätigten, dass sowohl 
das durch Ncoa3-knockdown beeinträchtigte Dendritenwachstum, als auch die 
gestörte miRNA-Funktion, ein Ergebnis der reduzierten Ago2 Expression ist. Folglich 
enthüllt diese Veröffentlichung einen neuen transkriptionellen Mechanismus für die 
Kontrolle von miRNA-abhängiger Repression in neuronaler Entwicklung. 
Zusammenfassend entziffern diese Befunde neuronale Genexpressionsprogramme, 
die synaptische Anpassungen kontrollieren und so möglicherweise in Lern- und 
Gedächtnisprozessen involviert sind. 
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Introduction 
1.1 Dendritic protein synthesis and synaptic plasticity 
The intriguing cognitive capabilities of our brain are enabled by ~100 billion (1011) nerve 
cells (neurons) which are interconnected by ~100 trillion (1014) specialized junctions 
(synapses) within complex neural circuits. In order to receive and integrate this 
extraordinary high number of synaptic inputs, neurons increase their surface through 
the formation of multiple, branched processes known as dendrites. Dendrites carry 
small protrusions called dendritic spines which are the major contact sites of excitatory 
synapses. Based on the results from many studies, spine size represents a good 
correlate of synaptic strength (Matsuzaki et al., 2004; Lippman and Dunaevsky, 2005). 
During postnatal development and in the adult organism, dendrites and synapses can 
adapt to changes in the environment in an activity-dependent manner. These 
adaptations are commonly referred to as neuronal plasticity and are thought to underlie 
both the correct development of neural circuits and memory formation in the adult 
(Flavell and Greenberg, 2008). The establishment of long-lasting morphological and 
functional changes of dendrites and synapses requires elaborate gene expression 
programs that include the regulation of transcription and translation. The activity-
dependent translation of dendritically localized mRNAs appears to be particularly 
important for excitatory synaptic plasticity during memory-related processes (Richter 
and Klann, 2009). Dendritic protein synthesis requires the active transport of thousands 
of mRNAs to synaptic sites within dendrites, where they are available for the rapid 
supply of new synaptic proteins in response to stimulation. Dendritically localized 
mRNAs encode for proteins involved in signaling (e.g. protein kinases), translational 
control (e.g. RNA-binding proteins), membrane trafficking (e.g. adapter molecules), and 
neurotransmission (e.g. neurotransmitter receptors) (Cajigas et al., 2012). The most 
widely expressed neurotransmitter receptors in the mammalian brain are α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPA-Rs). AMPA-Rs are 
ligand-gated cation channels composed of four subunits (GluA1-4) which are activated 
by the neurotransmitter glutamate. They are located at the postsynaptic side of 
glutamatergic synapses and their dynamic membrane trafficking is involved in the 
bidirectional modification of synaptic strength (Huganir and Nicoll, 2013). Since AMPA-
Introduction 
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Rs reside in the plasma membrane, the modification of their surface expression is 
mediated by orchestrated translational and membrane trafficking events. GluA1 and 2 
mRNAs are dendritically localized (Cajigas et al., 2012) and their local translation is 
tightly controlled, e.g. by the translational repressor protein eIF4E-BP2 (Ran et al., 
2013). As shown by several groups, microRNAs (miRNAs, see below) are also 
important regulators of GluA1 and 2 expression in the context of synaptic activity (Ho 
et al., 2014; Letellier et al., 2014; Hu et al., 2015). 
1.2 MicroRNAs 
MiRNAs are a family of non-coding RNAs with a length of ~21 nucleotides which 
negatively regulate the translation of specific mRNAs. In most cases, miRNAs bind via 
partial complementarity to the 3’ untranslated region (3’ UTR) of target mRNAs, thereby 
leading to translational repression and/or mRNA decay (Krol et al., 2010; Huntzinger 
and Izaurralde, 2011). 
Since miRNA binding requires only a relatively short complementary region within 
target 3’UTRs (the so-called seed pairing region), a single miRNA regulates up to 
hundreds of target mRNAs. This pleiotropic effect offers the possibility to coordinately 
control genes working in the same pathway. 
1.3 MiRNAs in the nervous system 
Especially in the nervous system, orchestrated translational control by miRNAs is an 
attractive concept in the context of activity-dependent protein synthesis. Indeed, many 
miRNAs are expressed in particular cell-types of the nervous system (Jovicic et al., 
2013). Several neuronal miRNAs were identified in the synaptodendritic compartment 
by microarray analysis of synaptosomes which are biochemical brain preparations 
enriched in pre- and postsynaptic components (Siegel et al., 2009). MiR-137, which is 
present at high levels in synaptosomes, was shown to regulate dendrite development 
(Smrt et al., 2010) and synaptic plasticity by acting presynaptically (Siegert et al., 2015). 
Intriguingly, genetic variants of MIR137 are associated with schizophrenia (Cummings 
et al., 2013; Ripke et al., 2014) and intellectual disability (Willemsen et al., 2011). 
Another well-characterized dendritic miRNA is miR-134. MiR-134-dependent regulation 
of Pumilio2 (Pum2) is required for activity-dependent dendrite growth and homeostatic 
synaptic plasticity (Fiore et al., 2009; Fiore et al., 2014). In addition, miR-134 negatively 
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affects dendritic spine size by inhibiting local translation of LIM-domain kinase 1 (Limk1) 
mRNA. MiR-134-dependent inhibition of Limk1 can be reversed by brain-derived 
neurotrophic factor (BDNF) (Schratt et al., 2006). Furthermore, overexpression of miR-
134 in mice interferes with memory formation by repression of the cyclic AMP-
responsive element-binding protein 1 (CREB1) and its downstream target BDNF (Gao 
et al., 2010). Under pathophysiological conditions, miR-134 is induced by epileptiform 
activity, and miR134 reduces epilepsy-associated cell death and seizure activity 
(Jimenez-Mateos et al., 2012). MiR-138 is another crucial miRNA in the brain which 
regulates the development of dendritic spines through the local translational control of 
the acyl-protein thioesterase 1 (APT1) (Siegel et al., 2009). A different important miRNA 
is miR-181a. It was described as a regulator of immune system function by controlling 
the expression of the cytokine TNF-alpha (Dan et al., 2015). In addition, miR-181a has 
been shown to function as a tumor suppressor in multiple studies (Shi et al., 2008; Shin 
et al., 2011; Huang et al., 2015). Within neurons, miR-181a is present in neuronal 
processes (Kye et al., 2007) and negatively regulates dendrite outgrowth (Liu et al., 
2013). 
1.4 MiRNA biogenesis and function 
MiRNA genes occur either as single genes, gene clusters or within introns of protein-
coding genes. The majority of miRNAs are transcribed by RNA polymerase II. The 
resulting primary miRNA transcript (pri-miRNA) contains a typical hairpin structure 
which serves as a substrate for the RNase III family enzymes Drosha and Dicer for two 
consecutive nucleolytic processing steps. In the nucleus, the microprocessor complex 
consisting of Drosha and DiGeorge syndrome critical region 8 (DGCR8) generates a 
~70 nucleotide precursor miRNA (pre-miRNA) by liberating the hairpin from the 
remaining pri-miRNA. After export to the cytoplasm, Dicer is assisted by Trans-
activation-responsive RNA-binding protein (TRBP) to cleave off the loop region of the 
pre-miRNA hairpin yielding a miRNA/miRNA* duplex. One of the two strands of the 
duplex is incorporated into the miRNA-induced silencing complex (miRISC) which 
mediates the repressive activity. The miRISC consists of two core factors, Argonaute 
(Ago) and GW182 proteins. Mammals express four Ago proteins (Ago1-4) which 
catalyze the binding of the miRNA to the target mRNA and further recruit GW182 
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proteins (Tnrc6a-c in mammals). The multi-domain GW182 proteins act as scaffolds to 
recruit further protein complexes involved in translational repression, mRNA decapping 
and mRNA degradation. In addition, a number of miRISC accessory proteins that are 
able to modulate the repressive activity have been identified (van Kouwenhove et al., 
2011). 
1.5 Regulation of miRNA activity 
The expression of miRNAs can be regulated at all stages of biogenesis (transcription, 
export and processing), which often involves the function of specific pre-miRNA-binding 
proteins (Krol et al., 2010). In addition, the gene regulatory activity of miRNAs can be 
regulated by altering miRISC function. Mechanistically, miRISC regulation can be 
achieved by posttranslational modification of the core miRISC components Ago or 
GW182 (Qi et al., 2008; Zeng et al., 2008; Rybak et al., 2009; Li et al., 2014). 
Furthermore the activity of the miRISC can be influenced by proteins that modulate 
miRISC recruitment to target mRNAs. These factors are often RNA-binding proteins 
(RBPs) that bind to sequence motifs that either overlap or are adjacent to miRNA 
binding sites within target 3’UTRs. Such RBPs have been shown to either promote or 
impede miRISC recruitment (Höck et al., 2007; Kedde et al., 2007; Nolde et al., 2007; 
Edbauer et al., 2010; Engels et al., 2012). The activity of RBPs which modulate miRISC 
can be modified by extracellular signals. For example, in response to cellular stress, 
HuR translocates from the nucleus to the cytoplasm where it relieves miR-122 
dependent repression of the cationic amino acid transporter 1 (CAT-1) mRNA 
(Bhattacharyya et al., 2006). Such signal-dependent switches in miRNA-dependent 
repression could be highly relevant for the regulation of dendritic protein synthesis and 
plasticity in neurons, however few examples have been described so far. They include 
the signal-dependent modification of the Ago-interacting proteins FMRP and 
Mov10/Armitage (Banerjee et al., 2009; Muddashetty et al., 2011). 
In principle, specific usage of the different Ago proteins by certain miRNAs could be a 
further means to control miRNA repressive function. However, conclusive evidence for 
a specific sorting of different miRNAs into the four mammalian Ago proteins is still 
missing (Azuma-Mukai et al., 2008; Hafner et al., 2010). Ago2 is the only family member 
with endonuclease activity, which enables target degradation in the case of perfect 
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complementarity between target mRNA and miRNA (Krol et al., 2010). Moreover, Ago2 
has essential roles which are independent of its nuclease activity but cannot be 
compensated by the other Ago proteins, e.g. during hematopoiesis (O'Carroll et al., 
2007). Together, these findings underscore apparently unique functions of Ago2 which 
cannot be compensated by the other Ago proteins. 
1.6 Ncoa3 
Ncoa3 (SRC-3, AIB-1) is a transcription factor belonging to the family of nuclear 
receptor co-activators (Ncoa 1-3) (Leo and Chen, 2000; Dasgupta et al., 2014). Ncoa3 
does not contact DNA directly, but interacts with nuclear receptors (e.g. estrogen and 
retinoic acid receptors) in a ligand-dependent manner. Nuclear receptor binding recruits 
Ncoa3 to specific elements in the promoters of target genes, where it interacts with 
general co-activators that modify chromatin structure. By controlling hormone-
dependent gene expression, Ncoa3 functions as an oncogene in various tumor types 
(Xu et al., 2009). Furthermore, Ncoa3 has cytoplasmic functions in signaling and 
translational control (Yu et al., 2007; Long et al., 2010). The transition of Ncoa3 
between cytoplasm and nucleus was shown to depend on phosphorylation (Amazit et 
al., 2007). In the brain, the function of Ncoa3 remains largely unknown. In a study 
performed in cortical neurons, Ncoa3 was shown to be phosphorylated upon treatment 
with all-trans retinoic acid, a lipid hormone that regulates local protein synthesis in the 
context of homeostatic synaptic plasticity (Aoto et al., 2008; Chai et al., 2009). However, 
Ncoa3 has not been implicated in the control of miRNA activity so far.  
1.7 Aims of this thesis  
Although previous studies have identified a number of miRNAs involved in the 
regulation of neuronal development and plasticity, the target genes regulated by these 
miRNAs were still poorly characterized. In particular, a direct modulation of synaptic 
glutamate receptor function by miRNAs had not been established. Moreover, the 
mechanisms that modulate miRNA function in neurons were similarly unexplored, 
especially with respect to an involvement of RNA-binding proteins.  
Therefore, in the context of two collaborative projects, I explored a potential regulation 
of AMPA-type glutamate receptor expression by the synaptic miRNAs miR-181a and 
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miR-137, with the aim to unravel the mechanism that underlies the regulation of 
synapse morphology and physiology by these miRNAs. 
As a main project, I investigated the function of a specific protein (Ncoa3) that was 
identified in a large-scale screen for miRNA modulatory factors in neurons. The 
objective here was to clarify the mechanism whereby the transcription factor Ncoa3 
controls miRNA activity and neuronal development. 
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2. Summary and personal contribution to cumulated publications 
2.1 Publication 1: “Dopamine-regulated microRNA miR-181a controls GluA2 
surface expression in hippocampal neurons.” (Saba et al., 2012) 
In the present publication, miR-181a was identified as a novel regulator of GluA2 
expression, with potential implications for synaptic plasticity mechanisms involved in 
the control of addiction. The nucleus accumbens processes reward and motivation as 
part of the mesolimbic system and is therefore involved in the establishment of 
addiction. Since miRNAs are important regulators of gene expression and synaptic 
plasticity, the study investigated synaptically localized miRNAs in the nucleus 
accumbens using microarray analysis. Using synaptosome fractionation, nine miRNAs 
were identified that were enriched more than 2-fold in synaptosomes compared to 
nucleus accumbens tissue (Table 1). For further analysis, we focused on miR-181a, 
since in silico miRNA target prediction algorithms detected this miRNA to target GluA2 
which is an important modulator of synaptic transmission (Fig. 2C). Furthermore, all 
follow-up experiments were performed in hippocampal neurons, since these cells are 
more amenable to experimental manipulation compared to neurons from nucleus 
accumbens. A functional interaction between miR-181a and GluA2 mRNA could be 
confirmed using overexpression and inhibition of miR-181a in reporter gene assays 
(Fig. 2D and 3C). MiR-181a expression was found to increase during in vitro 
development of neurons with highest levels at 14-20 days in vitro (DIV, Fig. 3A), a time 
period of intense synapse formation and remodeling. Overexpression of miR-181a 
reduced total GluA2 protein levels as well as GluA2 expression on the neuronal plasma 
membrane (Fig. 2F, 4B and C). Neuromorphological measurements by confocal 
microscopy in cells overexpressing miR-181a further showed a reduction in dendritic 
spine size and density (Fig. 4E and F). In agreement with the morphological data, 
electrophysiological recordings of neurons overexpressing miR-181a revealed a 
reduction in the frequency but not in the amplitude of mEPSCs (Fig. 5). Finally, 
treatment of neurons with the dopamine agonist SKF-38393 resulted in increased miR-
181a expression (Fig. 6A and B) and reduced expression of the miR-181a target GluA2 
in reporter gene assays (Fig. 6D). This effect was dependent on miR-181a, since 
mutation of the miR-181a site in the GluA2 reporter abolished dopamine 
Summary and personal contribution to cumulated publications 
 8 
responsiveness. Furthermore, acute administration of cocaine and amphetamine 
affected the expression of miR-181a in various regions of the mouse brain (Fig. 6E). In 
conclusion, this publication describes miR-181a as a critical regulator of AMPA-type 
glutamate receptors with implications for drug-induced adaptations. 
My contribution to this publication was to analyze the effects of miR-181a 
overexpression on GluA2 expression. The results of these experiments are presented 
in Figs. 2F, 4B, 4F. The methods used here are GluA2 protein quantification after miR-
181a overexpression in primary neurons by Western Blot (Fig. 2F) and 
immunocytochemistry (Fig. 4B). Furthermore, I analyzed the density of dendritic spines 
of hippocampal neurons after miR-181a overexpression (Fig. 4F). The results from my 
experiments helped to establish endogenous GluA2 as a target of miR-181a and 
provided support for a functional role of miR-181a in the regulation of dendritic spine 
density. 
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2.2 Publication 2: “MicroRNA-137 controls AMPA-receptor-mediated 
transmission and mGluR-dependent LTD.” (Olde Loohuis et al., 2015) 
Disease-associated mutations in the MIR-137 gene have been linked to intellectual 
disability and schizophrenia. In this publication, the molecular mechanisms underlying 
a potential synaptic function of miR-137 were investigated. The functionality of a 
bioinformatically predicted miR-137 binding site in the AMPA-type glutamate receptor 
subunit GluA1 was validated by reporter gene assays and endogenous protein analysis 
using miR-137 overexpression and inhibition (Fig. 1). Inhibition of miR-137 resulted in 
an increased density of dendritic spines, whereas neither overexpression nor inhibition 
of miR-137 altered the size of dendritic spines (Fig. 3B). In parallel, miR-137 
manipulation affected AMPA-R-dependent, but not NMDA-R-dependent mEPSC 
frequency as measured by patch-clamp recordings (Fig. 2). In agreement with the spine 
data, no alterations in either AMPA-R- or NMDA-R-dependent mEPSC amplitude were 
observed (Fig. 2E). Similarly, the number of silent synapses, i.e. synapses which 
contain NMDA- but not AMPA-Rs, were reduced after miR-137 inhibition and increased 
after miR-137 overexpression (Fig. 3I). This finding supports a mechanism whereby 
miR-137 controls the surface expression of functional AMPA-Rs. Since AMPA-R 
dynamics is important for activity-dependent synapse remodeling, a paradigm of 
synaptic plasticity (LTD) was used to further study the influence of miR-137. 
Pharmacological induction of LTD with the mGluR group I agonist 
Dihydroxyphenylglycine (DHPG) significantly increased mature miR-137 levels (Fig. 4) 
in an mGluR5-dependent manner. Furthermore, DHPG-mediated induction of miR-137 
was essential for the establishment of LTD (Fig. 4E). In summary, this publication 
provided evidence for an important role of miR-137 in synapse function and plasticity. 
Therefore, these findings might help to explain neurological symptoms associated with 
polymorphisms in the MIR-137 gene observed in mental retardation and schizophrenia. 
My contribution to the present publication was to demonstrate that miR-137 directly 
controls GluA1 translation. This was carried out with reporter gene assays using the 
GluA1 3’UTR. The expression of the reporter was increased after miR-137 inhibition in 
primary neurons which was not the case when the miR-137 binding site in the GluA1 
3’UTR was mutated (Fig. 1A, B). Together these data show that miR-137 actively 
represses the translation of GluA1 in neurons.  
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2.3 Publication 3: “A large-scale functional screen identifies Nova1 and Ncoa3 
as regulators of neuronal miRNA function.” (Störchel et al., 2015) 
As illustrated in the previous two publications, synaptic miRNAs are crucially involved 
in the control of neuronal growth, synapse formation and plasticity by regulating the 
translation of specific mRNAs. In order to identify neuronal proteins which regulate the 
repressive activity of miRNAs, a luciferase-based RNAi screen was performed. The 
screening of 286 RBPs in primary neurons identified 12 RBPs that were required for 
miRNA repressive activity. Among them were 10 RBPs that were previously unknown 
to be involved in miRNA regulation (Fig. 1A and B). Based on results from further 
validation experiments, we decided to focus on two of these candidates, Ncoa3 and 
Nova1 (Fig. 1C). Both proteins were shown to be expressed in the cytoplasm and 
nucleus of primary neurons in a developmental-dependent manner (Fig. 2). Further 
luciferase-based experiments showed that both proteins are required for the repressive 
activity of miR-134, let-7 and miR-138 on reporters carrying the 3’UTR of Limk1, Lin-
41 and APT1, respectively (Fig. 3). However, only Nova1 was essential for the 
regulation of an isolated miR-138 binding site (Fig. 3F). The endogenous protein levels 
of Limk1, a known miR-134 target, were elevated upon shRNA-mediated knockdown 
of Nova1 and Ncoa3 (Fig. 4A and B). Also, the knockdown of both proteins blocked 
miR-134-induced shrinkage of dendritic spines (Fig. 4C and D). Mechanistically, we 
demonstrated that Nova1 directly interacts with Ago proteins and target mRNAs using 
immunoprecipitation experiments (Fig. 5A and B). Direct recruitment of Nova1 to a 
reporter mRNA in tethering assays was sufficient to inhibit reporter gene expression 
(Fig. 5D). Together, our results suggest that Nova1 represses mRNA translation in 
neurons as a miRISC-interacting protein. Concerning the analysis of Ncoa3, we found 
that is essential for proper dendritic spine development and synaptic transmission (Fig. 
7). An shRNA-mediated knockdown of Ncoa3 reduced the amplitude of mEPSC, but 
not their frequency in dissociated hippocampal neurons (Fig. 7C-F). Furthermore, 
Ncoa3 knockdown significantly increased dendrite outgrowth in wild-type neurons, but 
not in neurons that lack miRNAs due to knockdown of Drosha (Fig. 6). Therefore we 
conclude that the dendrite growth regulatory function of Ncoa3 is dependent on 
miRNAs. Comparative gene expression analysis of wild-type and Ncoa3-deficient 
neurons by microarrays identified Ago2 as an Ncoa3-regulated gene (Fig. 8B). These 
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results were further confirmed by qPCR and Western Blotting (Fig. 8C and D). By using 
chromatin immunoprecipitation (ChIP) and luciferase reporter gene assays, we found 
that Ncoa3 was associated with the Ago2 promoter (Fig. 8E and F) which suggests that 
Ncoa3 transcriptionally regulates Ago2 expression. Finally, restoring Ago2 expression 
rescued the effects of Ncoa3 knockdown on dendrite outgrowth and expression of 
miRNA reporter genes (Fig. 9), which supports the concept that the cellular defects 
caused by Ncoa3 knockdown are a result of reduced Ago2 expression. In summary, 
this publication describes the identification and validation of two novel miRNA 
regulatory factors in neurons, with implications for nervous system development and 
brain physiology. 
In this publication, where I share first authorship, I generated most of the data related 
to Ncoa3. This includes the generation of expression vectors, reporter gene assays 
(Fig. 3B, 3D, 8F, 9B), dendrite growth analysis (Fig. 6 all, 9C-E), dendritic spine size 
analysis (Fig. 4C, 4D, 7A, 7B), gene expression analysis by microarray (Fig. 8B), qPCR 
(Fig. 8A, 8C), Western Blot (Fig. 2B, 2G, 4B, 8D), Immunocytochemistry (Fig. 2E, 2F, 
9A) and ChIP experiments (Fig. 8E). 
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3. Discussion 
3.1 miR-181a and miR-137 as synaptic regulators of AMPA-receptor subunits 
The first two publications to which I contributed describe in detail the molecular 
mechanisms whereby two synaptic miRNAs, miR-181a and miR-137, control synapse 
development and physiology. Intriguingly, both miRNAs were found to regulate 
subunits of the AMPA-type glutamate receptor, which plays a pivotal role in excitatory 
synapse function and plasticity. As such, these publications depict a potential 
mechanism whereby miRNA dysregulation could contribute to disorders such as 
addiction and schizophrenia.  
Our results obtained from synaptosome preparations of the rat nucleus accumbens 
(Pub. 1: Fig. 1) are consistent with an earlier study where qPCR analysis of total RNA 
isolated from laser-dissected dendrites of cultured rat hippocampal neurons identified 
the dendritic localization of miR-181a (Kye et al., 2007). This suggests that synapto-
dendritic localization of miR-181a might be commonly observed in different neuron 
types. In addition, miR-181a might not be exclusively transported to postsynaptic sites, 
since a passenger strand of miR-181a (miR-181a-1*) was detected in the axons of 
mouse cortical neurons (Sasaki et al., 2014). Earlier findings that miR-181a expression 
increases during mouse brain development, reaching highest levels in the adult (Miska 
et al., 2004), already indicated that miR-181a could be involved in synaptic plasticity 
and brain physiology. Consistently, the pattern of miR-181a expression during the 
maturation of cultured rat hippocampal neurons follows a similar trend (Pub. 1: Fig. 3A). 
An important finding was that application of a dopamine-agonist in mature neurons 
induced miR-181a expression (Pub. 1: Fig. 6A), directly implicating dopamine signaling 
in miR-181a biology. A connection between miR-181a and dopamine signaling is 
supported by previous publications which showed that miR-181a associates with Ago2 
in dopamine-receptor 2 (Drd2)-positive neurons of the mouse striatum, and that miR-
181a expression was induced in this region by administration of cocaine, a drug that 
stimulates dopamine signaling (Schaefer et al., 2010). Induction of miR-181a in the 
nucleus accumbens was also necessary for the establishment of cocaine-induced 
plasticity (Chandrasekar and Dreyer, 2009, 2011). Intriguingly, synaptic 
rearrangements induced by cocaine involve a specific removal of the GluA2 subunit 
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from AMPA-R heterodimers (Bellone and Lüscher, 2006). Indeed, we could provide a 
link between miR-181a induction and GluA2 removal by showing that miR-181a 
overexpression reduced both total GluA2 protein levels and GluA2 cluster size (Pub. 1: 
Fig. 2, 3, 4). Interestingly, when the cocaine-evoked dopaminergic innervations were 
mimicked in cell culture by application of a dopamine agonist, expression of a GluA2 
3’UTR reporter gene was reduced in a miR-181a-dependent manner (Pub. 1: Fig. 6D). 
Furthermore, the morphological changes caused by miR-181a expression (Pub. 1: Fig. 
4E and F) could be a direct consequence of reduced GluA2 levels, since GluA2 is both 
necessary and sufficient for dendritic spine formation and stability (Passafaro et al., 
2003). 
Taken together, publication 1 establishes miR-181a as a critical regulator of synapse 
development through the translational control of the AMPA-type glutamate receptor 
subunit GluA2. This mechanism could be involved in cocaine-induced 
neuroadaptations and addictive behavior that were previously shown to be miR-181a-
dependent (Chandrasekar and Dreyer, 2011). 
Deregulated dopaminergic signaling is also observed in schizophrenia and commonly 
used drugs to treat the symptoms of schizophrenia antagonize the dopamine receptor 
Drd2 (van Os and Kapur, 2009). Intriguingly, another miR-181 family member (miR-
181b) exhibits elevated levels in schizophrenia (Beveridge et al., 2008). Furthermore, 
GluA2 was identified as a target of miR-181b in a glioblastoma cell culture model used 
in the same study. Therefore, the regulation of GluA2 by miR-181 family members 
might also be relevant in deregulated dopaminergic transmission in schizophrenia.  
The synaptic enrichment of miR-137 was previously demonstrated by microarray 
profiling of rat forebrain synaptosomes from juvenile (postnatal day 15) rats (Siegel et 
al., 2009). Further validation experiments by independent methods (e.g. qPCR, 
Northern Blot or in-situ hybridization) are required to confirm synaptic enrichment of 
miR-137, especially since other studies failed to demonstrate dendritic or synaptic 
localization of miR-137 (Kye et al., 2007; Lugli et al., 2008). Interestingly, in publication 
2 we found an increase in mature miR-137 with a concomitant decrease in pre-miR-
137 after DHPG-induced LTD (Pub. 2: Fig. 4A and B). These findings are most easily 
explained by stimulus-dependent processing of pre-miR-137. Since pre-miR-137 is 
absent from dendrites, processing is likely happening within the neuronal cell soma 
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(Bicker et al., 2013). According to this model, accumulation of miR-137 at synapses 
during LTD would have to involve a rapid transport of the mature miRNA from the soma 
to the dendrite after pre-miRNA processing. Future mechanistic studies are required to 
resolve the molecular mechanisms underlying the dendritic transport of mature miR-
137 and other synaptic miRNAs in response to synaptic activity. 
Importantly, inhibition of endogenous miR-137 interfered with the establishment of 
mGluR-dependent LTD (Pub. 2: Fig. 4E, F and G). This might be clinically relevant 
since mGluRs are considered as potential drug targets for the treatment of 
schizophrenia (Chaki and Hikichi, 2011). mGluR-LTD requires dendritic protein 
synthesis and the miR-137 target GluA1 mRNA is dendritically localized. This together 
raises the possibility that the miR-137-dependent regulation of GluA1 happens 
postsynaptically in dendrites. In agreement with a dendritic function of miR-137, other 
established miR-137 target mRNAs, such as CACNA1C, CSMD1 and TCF4, were also 
identified in dendrites (Cajigas et al., 2012; Kwon et al., 2013). In addition to this 
putative postsynaptic function, miR-137 was recently found to affect synaptic vesicle 
release probability and their distribution as well as the expression of presynaptic 
proteins (Siegert et al., 2015). Although this study clearly delineates a functional 
involvement of miR-137 in presynaptic processes, it does not provide data with regard 
to the subcellular localization of miR-137. In conclusion, miR-137 appears to 
orchestrate both post- and presynaptic processes important for neurotransmission. 
3.2 Ncoa3 positively regulates miRNA activity by activating Ago2 expression 
Luciferase-based RNAi screens to identify miRNA regulators have been carried out 
before (Horman et al., 2013; Li et al., 2014), but we were the first to perform such a 
screen in primary neurons. Moreover, we focused on RBPs expressed in the 
mammalian brain based on a previous in-situ hybridization study (McKee et al., 2005). 
Together, these unique aspects of our screen allowed us to identify 10 novel miRNA 
regulatory proteins that had not been reporter before. Since I mainly focused on one of 
the newly identified regulators (Ncoa3) during my PhD thesis, I will limit the following 
discussion to this protein.  
As a family member of the nuclear receptor co-activators (Ncoa1-3 or also known as 
SRC1-3), Ncoa3 has been extensively studied in the context of nuclear receptor-
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dependent transcription, e.g. in estrogen receptor signaling related to breast cancer 
(Gojis et al., 2010). However, two studies assign additional cytoplasmic functions to 
Ncoa3, either as a signaling molecule in focal adhesions or as a translational co-
repressor in the immune response (Yu et al., 2007; Long et al., 2010). Consistent with 
this dual function of Ncoa3, I found that Ncoa3 is expressed in both the nuclear and 
cytoplasmic compartment of primary neurons (Pub. 3: Fig. 2). Having shown that Ncoa3 
stimulates miRNA function in neurons, I collected several lines of evidence that support 
a nuclear role of Ncoa3 in this process: I) By using UV-crosslinking experiments, I was 
unable to demonstrate a specific interaction of Ncoa3 with RNA (data not shown); II) 
the recruitment of Ncoa3 to the 3’UTR of a reporter gene mRNA in tethering assays 
had no effect on reporter gene expression (Pub. 3: Fig. 5) ; and III) using compartment-
specific expression of Ncoa3, I found that only nuclear expression of Ncoa3 was 
sufficient to restore miRNA-dependent repression of reporter genes in the context of 
Ncoa3 knockdown (data not shown). In support of a mechanism whereby Ncoa3 
promotes miRNA repression by inducing the expression of miRNA regulatory proteins, 
I was able to establish Ago2 as a direct transcriptional target of Ncoa3 using multiple 
independent approaches (Pub. 3: Fig. 8). Although the observed reduction of Ago2 
transcript levels after Ncoa3 knockdown is relatively small (30-40%), my results from 
rescue experiments (Pub. 3: Fig. 9) indicate that Ago2 regulation plays an important 
role in the control of miRNA activity and neuronal morphology by Ncoa3. In addition, 
Ncoa3 likely regulates neuronal morphogenesis by controlling other pathways. In fact, 
a set of genes which are implicated in microtubule dynamics, e.g. MAP9, Spastin and 
UHMK1 (Venoux et al., 2008; Cambray et al., 2009; Roll-Mecak and McNally, 2010), 
were downregulated by Ncoa3 knockdown. Future experiments are needed to 
determine the relevance of Ncoa3-regulated microtubule dynamics for neuronal 
development and plasticity. 
Given the redundancy of Ago proteins in mammalian RNAi, the strong phenotypic and 
gene regulatory consequences observed upon a 30-40% reduction specifically of Ago2 
are surprising at first. However, Ago2 was found to be rate-limiting in the RNAi pathway.  
Accordingly, excessive amounts of siRNAs are able to reduce available endogenous 
Ago2 complexes, with large consequences on cellular and organismal homeostasis 
(Grimm and Kay, 2006; Börner et al., 2013). I therefore speculate that Ago2 levels are 
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similarly rate-limiting in Ncoa3-regulated processes, e.g. dendrite development. Since 
global loss of miRNAs (e.g. induced by Drosha knockdown) does not affect dendrite 
outgrowth, the Ncoa3-Ago2 pathway likely affects only a specific subset of miRNA-
target interactions, in particular those involved in the negative control of dendrite 
growth. In the past, several miRNAs have been identified that negatively affect dendrite 
growth, e.g. miR-34a, miR-375, miR-137 and miR-181a (Abdelmohsen et al., 2010; 
Smrt et al., 2010; Agostini et al., 2011; Liu et al., 2013). Interestingly, the latter two were 
studied in the context of publications 1 and 2, where they were shown to regulate the 
translation of the AMPA-R subunits GluA1 and GluA2 respectively. However, both the 
GluA1 and GluA2 3’UTRs were unresponsive to Ncoa3 knockdown (data not shown). 
Two possibilities could help to explain this controversy. First, miR-137 and miR-181a 
could be loaded into Ago proteins other than Ago2, which would make them 
unresponsive to Ncoa3 manipulation. Although it was not assessed in primary neurons, 
Ago proteins exhibit only weak or no sorting preferences for particular miRNA 
sequences (Azuma-Mukai et al., 2008; Hafner et al., 2010). Furthermore, both miR-
181a and miR-137 have been previously shown to associate with Ago2 in the mouse 
brain in vivo (Schaefer et al., 2010). Therefore, the absence of miR-137 and miR-181a 
from Ago2-containing miRISC unlikely explains the failure of Ncoa3 to regulate 
GluA1/2. Alternatively, a specific mechanism which guides particular miRNA-Ago 
complexes to target mRNAs dependent on their 3’UTR context could be involved. In 
agreement with this model, we observed that two different target mRNAs (HMGA2 and 
Lin-41) of the same miRNA (let-7) displayed a differential responsiveness to Ncoa3 
knockdown. Moreover, reporters containing isolated miRNA-binding sites without 
3’UTR context were not affected by Ncoa3 knockdown (Pub. 3: Fig. 3d, E3d and data 
not shown). To identify Ncoa3-Ago2-dependent miRNA-complexes that inhibit dendrite 
growth, a candidate approach could be chosen in which miRNA-target pairs with known 
functions in dendrite growth are analyzed for their dependency on Ncoa3, e.g. the miR-
137/Mib1 interaction (Smrt et al., 2010). In addition, genome-wide Ago2 cross-linking 
immunoprecipitation (CLIP) experiments in wild-type and Ncoa3 knockdown neurons 
would represent a comprehensive and unbiased approach to identify Ncoa3-regulated 
Ago2 target mRNAs. 
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It should also be considered that Ago2 is not solely involved in miRISC function, but 
also plays an important role in controlling miRNA abundance by regulating the 
processing and stability of specific subsets of miRNAs (Diederichs and Haber, 2007; 
Cheloufi et al., 2010; Cifuentes et al., 2010). Profiling of miRNA expression by small 
RNA sequencing upon Ncoa3 knockdown could be used to systematically analyze a 
potential regulation of miRNA abundance by Ncoa3. 
It is noteworthy that Ncoa3 knockdown results in additional phenotypes in mature 
neurons, such as a reduction in dendritic spine size and synaptic strength (Pub. 3: Fig. 
7). These findings support a role of Ncoa3 in synapse physiology. At present, it is 
unclear if these phenotypes are similarly due to impaired miRNA function. If so, it will 
be important to identify the specific miRNA-target interactions regulated by Ncoa3 in 
the context of spine morphogenesis and synapse physiology.  
Finally, our findings in neurons establish a link between Ncoa3 and the miRNA pathway 
that could have important implications in other biological systems. For instance Ncoa3 
is widely studied in cancer where it positively influences hormone signaling and cell 
proliferation. Similarly, several miRNAs and miRNA pathway genes have been 
demonstrated to have oncogenic potential (Iorio and Croce, 2012). This raises the 
possibility that de-regulated miRNA activity might contribute to Ncoa3-dependent 
carcinogenesis. Therefore, a better understanding of how the Ncoa3-Ago2 pathway is 
regulated by nuclear hormones could provide important new insight into both neuronal 
plasticity (e.g. retinoic-acid induced homeostatic plasticity) (Aoto et al., 2008) and 
carcinogenesis (e.g. estrogen signaling in breast cancer) (Gojis et al., 2010). 
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Supplemental Table 1. List of primers and probes used in the study. 
Experimental 
procedure 
Targets in 
Rattus 
novergicus 
Applied 
Biosystems 
(AB) Assay 
ID 
Custom primers or probe sequences (5’-3’) 
qRT-PCR 
(miRNA) 
   
 Hsa-miR-
181a 
000480 - 
Hsa-miR-
181b 
001098 - 
Hsa-miR-
181c 
000482 - 
Hsa-miR-
181d 
001099 - 
Mmu-miR-
124a 
001182 - 
Hsa-miR-
99a 
000435 - 
Hsa-miR-
100 
000437 - 
U6 snRNA 001973 - 
SnoRNA 
202 
001232 - 
qRT-PCR 
(pre-miRNAs, 
mRNA) 
   
 Pre-miR-
181a-1 
- F: AACATTCAACGCTGTCGGTGAGT; 
R: GGTACAATCAACGGTCGATGGT 
Pre-miR-
181a-2 
- F: AACATTCAACGCTGTCGGTGAG;  
R: TACAGTCAACGGTTGGTGGT  
cFos - F: CATCATCTAGGCCCAGTGGC;  
R: AGGAACCAGACAGGTCCACATCT 
Arc - F: ACCGTCCCCTCCTCTCTTGA; 
R:TCTTTGTAATCCTATTTTCTCTGCCTT 
Beta-3-
tubulin 
- F: CCCCAGGGCTCAAGATGTC;  
R: CGCTTGAACAGCTCCTGGAT 
Gapdh - F: GCCTTCTCTTGTGACAAAGTGGA;  
R: CCGTGGGTAGAGTCATACTGGAA 
Northern Blot    
 Rno-miR-
181a 
- ACTCACCGACAGCGTTGAATGTT 
Rno-miR-
139-5p 
- CTGGAGACACGTGCACTGTAGA 
Rno-miR-
328 
- ACGGAAGGGCAGAGAGGGCCAG 
Rno-miR-
124a 
- TGGCATTCACCGCGTGCCAATT 
U6 snRNA - GCAGGGGCCATGCTAATCTTCTCTGTATCG 
Transfection 
(miRNA over-
expression)a 
   
 miR-181a 
sense  
- 5’Phospho-AACAUUCAACGCUGUCGGUGAGU 
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a. Oligonucleotides were annealed to form duplex RNA with 2 nucleotide long, 3’ overhangs. 
b. LNA modified oligonucleotides (power LNAs from Exiqon – PN 426850-00). 
 
 
 
  
miR-181a 
anti-sense 
- 5’Phospho-UCACCGGCAGCGUUGGGUGUUCC 
miR-134 
sense 
- 5’Phospho-UGUGACUGGUUGACCAGAGGGA 
miR-134 
anti-sense 
- 5’Phospho-CCUCUGGUCAACCAGUUAUACU 
Scramble 
Pre-miR 
- Proprietary sequence of Ambion 
Transfection 
(miRNA 
knock down)b 
   
 Hsa-miR-
181a 
- ACTCACCGACAGCGTTGAATG 
Negative 
control A 
- Proprietary sequence of Exiqon 
Cloning 
primers 
   
 GluA2-
3’UTR 
- F: CTAGTACAGGAAGTACTGGAGAAAA; 
R: TCTGAAGGTTTCACAACACTCTGAA 
Mutagenesis 
primers 
   
 miR-181a 
seed 
sequence 
binding site 
in GluA2 
- 
F:GAGTCCTGGCATGGGAATCAGTGTGACTGATC; 
R:GATCAGTCACACTGATTCCCATGCCAGGACTC 
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Supplemental Table 2. The 38 miRNAs consistently identified in the microarray experiments 
(p<0.01; n=3). 
miRNAs enriched 
or depleted in 
nucleus accumbens 
synaptoneurosomes 
(p<0.01) 
Average 
Fold 
enrichment 
± SD (n=3) 
SAM 
score 
ranka 
Ago2-
dependent 
in 
striatumb 
 
Cocaine- 
induced in 
Drd2 
expressing 
neuronsb 
 
Abundance 
in neurites 
relative to 
cell bodyc 
Reported 
to be 
depleted 
from synd 
Enriched miRNAs       
rno-miR-139-5p 3.12 ± 0.59 8.08 +  +  
rno-miR-328 3.11 ± 0.76 6.38 +  +  
rno-miR-410 2.41 ± 0.47 5.70 +    
rno-miR-433 2.00 ± 0.32 5.22 +  +  
rno-miR-379 1.40 ± 0.08 5.03     
rno-miR-132 1.47 ± 0.12 4.83   +  
rno-miR-185 1.46 ± 0.11 4.82 +  +  
rno-miR-7a 3.47 ± 1.36 4.73 + +   
rno-miR-181a 2.29 ± 0.55 4.53 + + +  
rno-miR-92b 1.53 ± 0.16 4.38     
rno-miR-17-5p 2.01 ± 0.51 3.84     
rno-let-7e 1.38 ± 0.15 3.28   +  
rno-miR-191 1.64 ± 0.34 3.16   +  
rno-miR-187 2.24 ± 0.89 3.06 +    
rno-miR-320 2.09 ± 0.75 2.96 +    
rno-miR-103 1.56 ± 0.31 2.87 +  +  
rno-miR-107 1.52 ± 0.31 2.58 +    
rno-miR-9* 1.19 ± 0.10 2.40     
rno-miR-9 1.92 ± 0.78 0.41   +  
rno-miR-218 1.06 ± 0.36 0.15 +    
Depleted miRNAs       
rno-miR-199a-3p 0.29 ± 0.02 19.56     
rno-miR-145 0.40 ± 0.04 9.54    + 
rno-miR-126 0.18 ± 0.05 9.47    + 
rno-miR-153 0.17 ± 0.05 7.98     
rno-miR-23b 0.59 ± 0.04 7.71 +  +  
rno-miR-23a 0.57 ± 0.05 7.08   +  
rno-miR-338* 0.55 ± 0.07 5.74 +    
rno-miR-539 0.61 ± 0.06 5.65 +    
rno-miR-30c 0.69 ± 0.04 5.50   +  
rno-miR-150 0.27 ± 0.10 4.87    + 
rno-miR-124 0.84 ± 0.01 4.56     
rno-miR-219-2-3p 0.64 ± 0.07 4.55 +    
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MiRNAs with ≥2-fold enrichment are highlighted in the table 
a. MiRNAs were ranked based on Significance Analysis of Microarrays (SAM) score. SAM is 
a high-throughput t-test specific for microarrays; higher the score, higher the significance (64). 
b. Reference 47  
c. Reference 31  
d. Reference 53 
 
 
 
 
 
 
 
  
rno-miR-204 0.44 ± 0.13 4.27 +    
rno-miR-143 0.48 ± 0.13 4.09    + 
rno-miR-128 0.74 ± 0.07 3.39 +  +  
rno-miR-26a 0.79 ± 0.10 2.38   +  
rno-miR-335 0.88 ± 0.73 0.72     
rno-miR-27b 0.89 ± 0.53 0.62   +  
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Supplemental Table 3. The relative abundance of enriched (≥2-fold) miRNAs in 
synaptoneurosomes (p<0.01; n=3). 
 
 
 
 
  
miRNAs enriched (≥2-fold) in 
NAcc synaptoneurosomes 
(p<0.01) 
Average relative abundance of 
enriched miRNAs ± SD 
Enriched miRNAs  
rno-miR-139-5p 4783 ± 1184 
rno-miR-328 548 ± 133 
rno-miR-410 752 ± 39 
rno-miR-433 4122 ± 798 
rno-miR-7a 4743 ± 373 
rno-miR-181a 9191 ± 1527 
rno-miR-17-5p 1699 ± 260 
rno-miR-187 973 ± 413 
rno-miR-320 2879 ± 206 
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Supplemental Table 4. A detailed description of miR-181a target genes similarly predicted by 
all three of the miRNA/target gene algorithms employed. 
Symbol Entrez Gene Name Location Type(s) 
ACSL1  acyl-CoA synthetase long-chain family 
member 1 
 Cytoplasm  enzyme 
ACVR2A  activin A receptor, type IIA  Plasma Membrane  kinase 
ARSJ  arylsulfatase family, member J  Extracellular Space  enzyme 
B4GALT1  UDP-Gal:betaGlcNAc beta 1,4- 
galactosyltransferase, polypeptide 1 
 Cytoplasm  enzyme 
BACH2  BTB and CNC homology 1, basic leucine 
zipper transcription factor 2 
 Nucleus  transcription regulator 
CARD11  caspase recruitment domain family, 
member 11 
 Cytoplasm  kinase 
CBX7  chromobox homolog 7  Nucleus  other 
CD4  CD4 molecule  Plasma Membrane  transmembrane 
receptor 
CNTN4  contactin 4  Plasma Membrane  enzyme 
CPD  carboxypeptidase D  Extracellular Space  peptidase 
CTDSPL  CTD (carboxy-terminal domain, RNA 
polymerase II, polypeptide A) small 
phosphatase-like 
 Nucleus  other 
E2F7  E2F transcription factor 7  Nucleus  transcription regulator 
EED  embryonic ectoderm development  Nucleus  transcription regulator 
EIF4A2  eukaryotic translation initiation factor 4A2  Cytoplasm  translation regulator 
EPC2  enhancer of polycomb homolog 2 
(Drosophila) 
 unknown  other 
FNDC3A  fibronectin type III domain containing 3A  Cytoplasm  other 
FOS  FBJ murine osteosarcoma viral oncogene 
homolog 
 Nucleus  transcription regulator 
GOLGA1  golgin A1  Cytoplasm  other 
GLUA2  glutamate receptor, ionotropic, AMPA 2  Plasma Membrane  ion channel 
GRM5  glutamate receptor, metabotropic 5  Plasma Membrane  G-protein coupled 
receptor 
IL1A  interleukin 1, alpha  Extracellular Space  cytokine 
KLF6  Kruppel-like factor 6  Nucleus  transcription regulator 
KLHL5  kelch-like 5 (Drosophila)  unknown  other 
KPNB1  karyopherin (importin) beta 1  Nucleus  transporter 
LBR  lamin B receptor  Nucleus  enzyme 
LRRC8D  leucine rich repeat containing 8 family, 
member D 
 Plasma Membrane  G-protein coupled 
receptor 
MAMDC2  MAM domain containing 2  Extracellular Space  other 
MAP3K10  mitogen-activated protein kinase kinase 
kinase 10 
 Cytoplasm  kinase 
MMP14  matrix metallopeptidase 14 (membrane-
inserted) 
 Extracellular Space  peptidase 
NPTXR  neuronal pentraxin receptor  Plasma Membrane  transmembrane 
receptor 
NR6A1  nuclear receptor subfamily 6, group A, 
member 1 
 Nucleus  ligand-dependent 
nuclear receptor 
OSBPL3  oxysterol binding protein-like 3  Cytoplasm  other 
PAK4  p21 protein (Cdc42/Rac)-activated kinase 
4 
 Cytoplasm  kinase 
PBX3  pre-B-cell leukemia homeobox 3  Nucleus  transcription regulator 
PI4K2B  phosphatidylinositol 4-kinase type 2 beta  Cytoplasm  kinase 
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PIAS3  protein inhibitor of activated STAT, 3  Nucleus  transcription regulator 
PLCL2  phospholipase C-like 2  Cytoplasm  enzyme 
PLEKHJ1  pleckstrin homology domain containing, 
family J member 1 
 unknown  other 
PPP1R12B  protein phosphatase 1, regulatory 
(inhibitor) subunit 12B 
 Cytoplasm  phosphatase 
PRKCD  protein kinase C, delta  Cytoplasm  kinase 
RAB11FIP2  RAB11 family interacting protein 2 (class 
I) 
 Cytoplasm  other 
RAN  RAN, member RAS oncogene family  Nucleus  enzyme 
RGMA  RGM domain family, member A  Plasma Membrane  other 
SCHIP1  schwannomin interacting protein 1  Cytoplasm  other 
SEMA4C  sema domain, immunoglobulin domain 
(Ig), transmembrane domain (TM) and 
short cytoplasmic domain, (semaphorin) 
4C 
 Plasma Membrane  other 
SLITRK1  SLIT and NTRK-like family, member 1  unknown  other 
SOX6  SRY (sex determining region Y)-box 6  Nucleus  transcription regulator 
TARDBP  TAR DNA binding protein  Nucleus  transcription regulator 
TIMP3  TIMP metallopeptidase inhibitor 3  Extracellular Space  other 
TOM1L1  target of myb1 (chicken)-like 1  Cytoplasm  other 
UBP1  upstream binding protein 1 (LBP-1a)  Cytoplasm  transcription regulator 
YWHAG  tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, gamma 
polypeptide 
 Cytoplasm  other 
ZC3H6  zinc finger CCCH-type containing 6  unknown  other 
ZDHHC7  zinc finger, DHHC-type containing 7  Cytoplasm  enzyme 
ZIC2  Zic family member 2 (odd-paired 
homolog, Drosophila) 
 Nucleus  transcription regulator 
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Supplemental Table 5. A detailed description of the gene ontology assignments of the target 
genes predicted for miR-181a. 
 
  
Category p-value Molecules 
 Neurological Disease 4.78E-05-2.75E-02  GRM5, FOS, TIMP3, RAN, GLUA2, EIF4A2 
 Nervous System Development and Function 5.36E-05-4.61E-02  GRM5, FOS, ZIC2, GLUA2 
 Cell-To-Cell Signaling and Interaction 7.88E-04-4.61E-02  GRM5, FOS, GLUA2 
 Cell Death 1.68E-03-4.2E-02  GRM5, FOS, CD4, TARDBP, GLUA2 
 Cell Signaling 4.28E-03-2.54E-02  GRM5, GLUA2 
 Cellular Assembly and Organization 4.28E-03-4.28E-03  FOS, TARDBP 
 Small Molecule Biochemistry 4.28E-03-2.12E-02  GRM5, FOS 
 Vitamin and Mineral Metabolism 4.28E-03-2.54E-02  GRM5, GLUA2 
 Molecular Transport 8.53E-03-2.12E-02  FOS, GLUA2 
 Tissue Development 8.53E-03-8.53E-03  ZIC2 
 Amino Acid Metabolism 2.12E-02-2.12E-02  FOS 
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Supplemental Table 6. Detection of pre-miR-181a-2 in synaptoneurosome preparations by 
microarray screening. 
Array 
Pre-
miRNA 
forma,b 
Average relative 
abundance (n=8 spot 
replicates) Fold 
enrichment 
in SYN 
(p<0.01) 
SYN/NAcc whole tissue 
(Cy3/Cy5)c 
SYN(Cy3-
labelled) 
NAcc 
Whole 
tissue 
(Cy5-
labeleld) 
#1 
pre-miR-
181a-1 
nd nd - - 
pre-miR-
181a-2 
265.76 262.91 ns 
 
#2 
pre-miR-
181a-1 
nd nd - - 
pre-miR-
181a-2 
3998.22 2522.13 1.59 
 
#3 
pre-miR-
181a-1 
nd nd - - 
pre-miR-
181a-2 
5700.88 2222.43 2.55 
 
 
a. and b. Custom microarray detection probes were designed for pre-miR-181a-1 and pre-miR-
181a-2 loop regions based on pre-miRNA stem-loop structures found in Sanger miRBase 
Release 13.0 based on accession numbers MI0000953 and MI0000925, respectively. 
c. Representative regions of microarray images are shown. 
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4.2 Olde Loohuis et al., 2015 
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4.3 Störchel et al., 2015 
Synopsis 
 
The identification of two novel modulators of miRNA function reveals an additional 
layer of transcriptional and post‐transcriptional control of Argonaute proteins and adds 
further insight on the central role for miRNAs in neurogenesis. 
 Large‐scale RNAi screen identifies novel miRNA regulatory proteins in primary 
neurons. 
 Ncoa3 and Nova1 are required for the repressive activity of the spine‐
regulating miR‐134. 
 Nova1 is a general, miRISC‐associated miRNA regulatory RBP in neurons. 
 Ncoa3 regulates a specific subset of miRNA target interactions involved in the 
control of dendritogenesis. 
 Ncoa3‐dependent transcriptional regulation of the miRISC protein Ago2 is 
required for the control of miRNA activity and dendritogenesis. 
Keywords: Ago2, dendrite, miRNA, Ncoa3, Nova1 
Received November 24, 2014. 
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Expanded view 
Material and Methods 
DNA constructs 
The firefly reporter constructs UBE3A-luc, APT1-luc, LIN41-luc WT, LIN41-luc mutant 
and LIMK1-luc were generated by inserting the corresponding 3’UTRs downstream of 
the firefly gene into the XbaI restriction site of pGL3-promoter or pGL4.13 (Promega). 
UBE3A-luc contains a 606 bp fragment of the rat UBE3A 3’UTR (Valluy J. et al., 2015). 
APT1-luc is derived from pGL3-Apt1 (Siegel et al., 2009). The wildtype and mutant 
3’UTRs of C.elegans LIN41 were kindly provided by D. Bartel. LIN41 WT 3’UTR was 
excised by NotI and MssI and LIN41 mutant 3’UTR was PCR amplified. The LIMK1 
3’UTR was PCR amplified from pGL3-Limk1 (Schratt et al., 2006). The 138-sponge-luc 
reporter was generated by inserting six binding sites for miR-138 carrying a bulge at 
position 9-12 (Ebert et al., 2007) into the XbaI site of pGL4.13. The ctrl sponge was 
created by inserting the reverse sequence of 138 sponge in pGL4.13. The renilla gene 
from phRL-TK was first cloned into pGL3-promoter using unique NcoI and XbaI sites 
and subsequently excised with HindIII and XbaI to generate pGL4-RL. For GFP-fusion 
proteins, open reading frames from a mouse brain cDNA library (C57BL/6) were PCR 
amplified and inserted into pEGFP_C1 (Clonetech) using the indicated restriction sites. 
The open reading frame (ORF) of Ncoa3 was amplified by PCR from a mouse cDNA 
clone (Clone ID: 30104508, Openbiosystems) and inserted to KpnI and AgeI restriction 
sites of pEGFP_N1 (Clontech). Silent mutations were introduced by site directed 
mutagenesis to generate shRNA-resistant Nova1 (Nova1R) and Ncoa3 (Ncoa3R). A 
predicted nuclear receptor binding site in the mouse Ago2 promotor (GRCm38/mm10, 
chr. 15 pos. 73185409-73185468) was cloned into the BglII and HindIII sites of pGL4. 
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For improved expression, a minimal promoter was further inserted to the HindIII site by 
oligo annealing and ligation. The Flag/HA-Ago2 expression vector was kindly provided 
by Thomas Tuschl. For both types of shRNA expression vectors, pSuper basic 
(oligoengine) and AAV (Christensen et al., 2009), the same DNA oligos were annealed 
and ligated into the BglII and HindIII restriction sites. 
Plasmids containing wild-type and mutant 3’UTRs of mouse IQGAP1 and HMGA2 were 
kindly provided by D. Bartel. The 3’UTRs were excised using the SacI/XbaI and 
XbaI/NotI restriction sites respectively and ligated to the XbaI site of pGL4 after blunt 
end generation. 
Antibodies 
Immunohistochemistry (ICC) or Western Blot analysis (WB) at the given dilution: rabbit 
anti-Ncoa3 (SRC-3 clone 5E11 from  Cell Signaling, WB 1:1000, ChIP), mouse anti-
Ncoa3 (AIB-1 clone34 from BD Biosciences, ICC: 1:200), rabbit anti-MAP2 (Cell 
Signaling cat.# 4542 , ICC: 1:200), mouse anti-MAP2 (clone HM-2 from Sigma-Aldrich, 
ICC: 1:2000), rabbit anti--Tubulin (Cell Signaling cat.# 2144, WB: 1:5000), mouse anti-
-Actin (clone AC-15 from Sigma-Aldrich, WB: 1:10,000), rabbit anti-HDAC2 (ab32117 
from Abcam, WB: 1:5000), mouse anti-Limk1 (clone 42 from BD Biosciences, WB: 
1:750), mouse anti-Ago2 (clone 2D4 from Wako, WB: 1:1000), rabbit anti-Ago2 
(ab32381 from Abcam, ICC: 1:200), chicken anti-GFP (ab13970 from Abcam, WB: 
1:10,000), rabbit anti-Nova1 (Merck Millipore cat.# 07-637, WB: 1:1500; ICC: 1:250), 
rabbit anti Nova-pan (obtained from R. Darnell; WB: 1:5000), rabbit anti-HA (ab9110 
from Abcam, ICC: 1:500), mouse anti-Flag (clone M2 from Sigma-Aldrich, WB: 1:1000), 
rabbit anti-Drosha (sc-33778 from SCBT, WB: 1:500). 
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Species specific secondary antibodies for WB were HRP-conjugated (Calbiochem) and 
applied at 1:20,000 dilutions. 
Secondary antibodies for ICC were anti-rabbit conjugated to Alexa 488, anti-mouse 
conjugated to Alexa 647 and anti-rabbit conjugated to Alexa 647 (Life technologies) at 
a dilution of 1:1000. 
RNA extraction and Reverse Transcription-quantitative PCR (RT-qPCR) 
For RNA extraction, hippocampal neurons were cultured in the presence of FUDR and 
infected on 4DIV. Total RNA was extracted on 14DIV using mirVana miRNA isolation 
Kit (Ambion). RNA was further treated with Turbo DNase (Ambion) according to the 
manufacturer’s protocol. After denaturation of the DNase for 10 min. at 75°C in the 
presence of 15 mM EDTA we reverse transcribed 1 g total RNA to cDNA using the 
iScript cDNA synthesis Kit (BioRad) supplemented with Mg2+ (final concentration 6 mM 
MgCl2 and 12 mM EDTA). Quantitative PCR was processed in triplicates with 10l total 
volume (0.67 l cDNA and 0.25 M primer concentration) using the iTaq SYBR Green 
Supermix with ROX (BioRad) on a Step One Plus instrument (Applied Biosystems). 
Luciferase assay 
Hippocampal neurons (11DIV) or cortical neurons (5DIV, 12DIV) were transfected as 
above in duplicates with 50-100 ng of the indicated pGL4 construct, equal amount of 
pGL4-RL and either 10 ng of the given pSuper vector or 7,5 pmol of siRNA duplex, or 
co-transfected with 5 pmol of miRNA duplex RNA (miR-134 or miR-138) (amount for 
one well of 24 well plate). Lysis was carried out 2-3 days later and the activity of both 
firefly and renilla was measured using the Dual Luciferase Reporter System (Promega) 
on the GloMax R96 Microplate Luminometer (Promega). Firefly activity was normalized 
to renilla activity and a basal condition which did not contain a shRNA expression vector 
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or siRNA was set as 1. Tethering experiments were performed by co-transfecting 
cortical neurons at 5DIV with 150 ng pCI-Neo-NHA or 250-400 ng NHA-fusion 
constructs, 50 ng of pRL-5boxB (obtained from R. Pillai) and 50 ng of pGL4.13 
(Promega). Luciferase assay was performed 2 days after transfection and renilla 
activity was normalized to firefly activity. 
Western blot analysis 
The concentration of extracts was determined by BCA assay (Pierce) and equal protein 
amounts were separated on a SDS-PAGE. After wet transfer (BioRad) to a PVDF 
membrane (Millipore) unspecific binding was blocked by incubation with 5% milk 
powder in Tris-buffered saline containing 0.1% Tween 20 (TBS-T). The same milk 
solution was used to dilute primary and secondary antibodies which were incubated at 
4°C overnight or for 1 h at RT respectively, each followed by 3 wash steps with (TBS-
T) for 10 min. Secondary HRP-conjugated antibodies were detected using the ECL 
Prime Western Blotting Detection Reagent (GE Healthcare). Band intensities of 
scanned films were measured with Image J. 
Immunocytochemistry and confocal microscopy 
For microscopic analysis hippocampal neurons were fixed by 4% 
paraformaldehyde/sucrose in PBS for 15 min. followed by three PBS washes. For 
analysis of neuronal morphology (see below), the GFP expressing cells were mounted 
directly in Aquapoly (Polysciences). For immunocytochemistry the cells were pre-
incubated with GDB (20 mM NaPO4 pH 7.4, 450 mM NaCl, 0.3% Triton X-100, 0.1% 
Gelatine) for 10 min. followed by incubation with the primary antibody for 1 h at RT 
diluted in GDB. After the cells were washed four times with PBS, the secondary 
antibody was applied for 1 h at RT diluted in GDB. After three further PBS washes, 
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Hoechst was incubated at 1:5000 in PBS for 5 min. and the cells were mounted as 
above. 
All images were acquired with a LSM 5 Pascal (Zeiss) microscope. Presented 
immunocytochemistry images are the maximum projections of 2-4 confocal stacks with 
a z-distance of 0.5-1 m. Measurements of average signal intensity and x-y-distance 
as well as further image cropping/magnification steps were carried out with Image J 
software. 
Primers 
All primer sequences are given 5’ to 3’. The following primers were used for qPCR: 
Ncoa3 FW: GCTTCGTCTCGACCCACTTC 
Ncoa3 REV: GGTCGGATGCCTTGTCCTAC 
Ago1 FW: TCATTATCGTCATCCTGCCCG 
Ago1 REV: GGCAGAGGTTGGACAGAGTC 
Ago2 FW: TCACATTCATCGTGGTGCAGA 
Ago2 REV: TCTTTGTGTCGACGGTTGTG 
Ago3 FW: GCTGTAGGCGACGCAAGTTC 
Ago3 REV: TGAAAGCTCCAGGCAGAAGAG 
Ago4 FW: GTTCAGTCAGGAGGTCGTGC 
Ago4 REV: TGGCCAAGCTACCTGTTTCA 
Tnrc6a FW: GCTCAAGTGCCTCCTCCATT 
Tnrc6a REV: GGTTCAGCATGGCTACCTGT 
Tnrc6b FW: CCCATAGGACACAACCCCAC 
Tnrc6b REV: CTCCAAGGAGATGCCGGTTT 
Tnrc6c FW: CACTTTTGCCAGAACTTACTAAGAC 
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Tnrc6c REV: ACAGGCAGATGCACGTTTG 
Dicer FW: CAGTTGTCCATCATGCCCTC 
Dicer REV: CTCAGCGCCACTCTTGAGAA 
Trbp FW: CAGTCTGAGTGCAACCCTGT 
Trbp REV: TGGTGAACTCTTTGCGGTGA 
Arhgdib FW: TACAGAGACACACAGGGCGG 
Arhgdib REV: CGGCTTGTAGTTGAGCTTGC 
Htra4 FW: GGCTCCGGAACTCCGATATG 
Htra4 REV: ATCCCAATCACCTCGCCATC 
Gpr3 FW: AACCCGGTCATTTACGCCTT 
Gpr3 REV: CTGGCGGACCTAACCTTCTG 
Spast FW: GCGCATCGACGAGGAAGAG 
Spast REV: TGTTCACCTTGGCCCGTAAC 
Cyb5r3 FW: TTCAAGGACACGCATCCCAA 
Cyb5r3 REV: GGACTTCTTGTCTGCACGGA 
Map9 FW: GGCAGCGGTTTATCAGGAGT 
Map9 REV: CCAGGCCTCAAATGACGCTA 
U6 snRNA FW: CTCGCTTCGGCAGCACA 
U6 snRNA REV: AACGCTTCACGAATTTGCGT 
GAPDH FW: GCCTTCTCTTGTGACAAAGTGGA 
GAPDH REV: CCGTGGGTAGAGTCATACTGGAA 
Limk1 FW: CCTCCGAGTGGTTTGTCGA 
Limk1 REV: CAACACCTCCCCATGGATG 
Rgs4 FW: ACAAGCCGGAACATGTTAGAG 
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Rgs4 REV: AGACTTGAGGAAACGACGGT 
 
The following oligos were used to create shRNA expression constructs: 
Control shRNA  FW1: GATCCCCAAACCTTGTGGTCCTTAGGTTCAAGAGA 
   FW2: CCTAAGGACCACAAGGTTTTTTTTA 
REV1: AGCTTAAAAAAAACCTTGTGGTCCTTAGGTCTCTTGAA 
REV2: CCTAAGGACCACAAGGTTTGGG 
Ncoa3 shRNA#1 FW1: GATCCCCGCAGCAGTAATGATGGATCTTCAAGAGA 
FW2: GATCCATCATTACTGCTGCTTTTTA 
REV1: 
AGCTTAAAAAGCAGCAGTAATGATGGATCTCTCTTGAA 
REV2: GATCCATCATTACTGCTGCGGG 
Ncoa3 shRNA#2  FW1: GATCCCCGGAGACAGTGAGACAGATATTCAAGAGA 
(used in all major  FW2: TATCTGTCTCACTGTCTCCTTTTTA 
experiments)  REV1: 
AGCTTAAAAAGGAGACAGTGAGACAGATATCTCTTGAA 
REV2: TATCTGTCTCACTGTCTCCGGG 
Nova1 shRNA FW1: GATCCCCGGTACTACTGAGAGGGTTTTCAAGAGA 
FW2: AAACCCTCTCAGTAGTACCTTTTTA 
REV1: AGCTTAAAAAGGTACTACTGAGAGGGTTTTCTCTTGAA 
REV2: AAACCCTCTCAGTAGTACCGGG 
Drosha shRNA FW1: GATCCCCCAACATAGACTACACGATTTTCAAGAGA 
FW2: AATCGTGTAGTCTATGTTGTTTTTGGAAA 
REV1: AGCTTTTCCAAAAACAACATAGACTACACGATTTCTCTTGAA 
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REV2: AATCGTGTAGTCTATGTTGGGG 
DGCR8 shRNA FW1: GATCCCCAACAATTTGGAGACTAGATGAATTCAAGAGA 
FW2: TTCATCTAGCTCCAAATTGTTTTTTTGGAAA 
REV1: 
AGCTTTTCCAAAAAAACAATTTGGAGCTAGATGAATCTCTTGAA 
REV2: TTCATCTAGCTCCAAATTGTTGGG 
 
The following primers were used to clone the mouse Ncoa3 ORF to pEGFP_N1: 
Ncoa3-KpnI-FW: GACTGGTACCATGAGTGGACTAGGCGAAAG 
Ncoa3-AgeI-REV: GACTACCGGTGTGCAGTATTTCTGATCGG 
The following primers were used to clone the mouse Nova1 ORF to pEGFP_C1: 
Nova1-XhoI-FW: GACTCTCGAGGCATGGCGGCAGCTCCCATTC 
Nova1-SmaI-REV: GACTCCCGGGTCAACCCACTTTCTGAGGATTGGC 
The following primers were used to clone the mouse Ewsr1 ORF to pEGFP_C1: 
Ewsr1-XhoI-fw: GACTCTCGAGGCGCGTCCACGGATTACAGT 
Ewsr1-SmaI-rev: GACTCCCGGGCTAGTAGGGCCGGTCTCTG 
 
The following primers were used for site directed mutagenesis: 
Ncoa3R-FW: GTGCCATCCTAAAGGAGACCGTTCGCCAGATACGGCAAATAAAAG 
Ncoa3R-REV: CTTTTATTTGCCGTATCTGGCGAACGGTCTCCTTTAGGATGGCAC 
Nova1R-FW: GATTTTTATCCAGGTACCACCGAGCGGGTTTGCTTGATCCAGG                     
Nova1R-REV: CCTGGATCAAGCAAACCCGCTCGGTGGTACCTGGATAAAAATC 
 
The following primers were used to clone 3’UTRs to pGL4: 
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LIN41-FW: GATCTCTAGACACTTTCTTCTTGCTCTTTAC 
LIN41-REV: GATCGCTAGCTTTATTCCAATTATGTTATCAG 
LIMK1-FW: CTTCTAGAGATACTTGGAGGATAGACCCTCACC 
LIMK1-REV: GCCCCGACTCTAGCTAGCGGGAGCACAGAATTGAT 
 
The following primers were used for cloning of NHA-fusion constructs: 
NHA-Nova1-Xba1-FW: TCTCTAGAATGGCGGCAGCTCCCATTCAGCAGAACG 
NHA-Nova1-Not1-REV: 
CCGGTGGCGGCCGCGTCAACCCACTTTCTGAGGATTGGCAG  
NHA-Nova1-del1-Not1-REV:     
CTGTGGATCCTCTGCGGCCGCCTGCTAGATAAGTTCAACAG 
NHA-Nova1-del2-Xba1-FW:        
TGAATCTAGAATCCAGAAGATACAAGAGGATCCACAGAGTG 
NHA-EGFP-FW: CCACCGGTCGACACCATGGTGAGCAAGGGCG 
NHA-EGFP-REV: ATCTAGAGTCGCGGCCGCTTTACTTGTAC 
NHA-Ncoa3-MluI-FW: GACTACGCGTATGAGTGGACTAGGCGAAAG 
NHA-Ncoa3-XbaI-REV: GATCTCTAGATCAGCAGTATTTCTGATCGGGG 
 
The following primers were used for cloning of the mouse Ago2 nuclear receptor 
element and the minimal promotor to pGL4.13: 
Ago2-RE-FW1: GATCTGCCGGGAGGTGGCGGTGTGGTCACG 
Ago2-RE-FW2: CGCACGGGTCTGGCCGCGTCCAAGTTCAAGCTCTGA 
Ago2-RE-REV1: ACCCGTGCGCGTGACCACACCGCCACCTCCCGGCA 
Ago2-RE-REV2: AGCTTCAGAGCTTGAACTTGGACGCGGCCAG 
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Min-prom-FW1: AGCTTAGACACTAGAGGG 
Min-prom-FW2: TATATAATGGAAGCTCGACTTCC 
Min-prom-FW1: AGCTGGAAGTCGAGCTTCC 
Min-prom-REV2: ATTATATACCCTCTAGTGTCTA 
 
The following primers were used to amplify rat genomic regions proximal to the 
transcriptional start site in ChIP experiments: 
Ago2-genomic-FW: ATGGTGCACCCTAAGCTTCC 
Ago2-genomic-REV: TGTGATGAAGTGGATCTGCACG 
Cyb5r3-genomic-FW: AGAATGGCAGTGAAGCACCA 
Cyb5r3-genomic-REV: ATCTGCCCTGGAAGATTGCC 
Map9-genomic-FW: ATAAGCTGATAGGGCACTGCG 
Map9-genomic-REV: AACCGACTGGTCTCTTGGGT 
Spast-genomic-FW: CCAGTCAGACTCCTGCGAAC 
Spast-genomic-REV: AGATCTGGGGTTTCGATGGC 
beta-globin-genomic-FW: TCTAGAAGGTACCCTCATGGCTGAA 
beta-globin-genomic-REV: GGATATGCCCTGTGGAGTGTTGAC 
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Figure legends 
Figure E1: Validation of siRNA specificity in luciferase reporter assays.  
A) Primary rat cortical neurons were transfected with the unmodified pGL4 (empty-luc) 
and luciferase activity was quantified as in Fig. 1 C and D. B) Western blot analysis 
with lysates obtained from HEK293 cells that had been co-transfected with the 
indicated GFP-tagged protein expression constructs and different siRNAs. Upper 
panels: anti-GFP Western. Lower panel: anti-ß-Actin Western (loading control). For 
GFP-Ewsr1, a non-specific band (*) serves as internal loading control. 
Figure E2: Nova1 expression in cortical neurons and validation of the anti-Ncoa3 
antibody for ICC. 
A) Western blot analysis of Nova1 protein using whole cell extracts harvested from rat 
cortical neurons at the indicated days of in vitro (DIV) culture. ß-actin was used as a 
loading control. B) Western blot analysis of Nova1 protein using brain extracts from 
Nova1 knockout mice. C) Western blot analysis of Ncoa3 protein using whole cell 
extracts harvested from FUDR-treated rat hippocampal neurons at the indicated days 
of in vitro (DIV) culture. -Tubulin was used as a loading control. D) 
Immunocytochemistry analysis of Ncoa3 expression (red) in hippocampal neuron 
cultures at 7DIV. MAP2 staining (green) was used to visualize neurons, Hoechst (blue) 
to visualize nuclei. Right: Magnification of insert depicted on the left. For simplicity, only 
the Ncoa3 signal is shown in greyscale. Cell and nuclear outlines derived from MAP2 
and Hoechst staining, respectively, are shown in yellow. Scale bar = 10 m. E) 
Immunocytochemistry for Ncoa3 (white in left panel, red in right panel) in hippocampal 
neurons (14DIV) that were transfected with the indicated shRNA expression vectors 
and GFP. F) Quantification of the average Ncoa3 signal intensity in the soma of 
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transfected neurons (right panel). Presented values are mean ± standard deviation 
from three independent experiments (10 cells per condition) with normalization to a 
basal condition without shRNA. **p<0.01 (student’s t-test). Scale bar = 50 m.  
Figure E3: Validation of Ncoa3/Nova1 knockdown and target regulation. 
A, B) Western blot analysis of Nova1 (A) and Ncoa3 (B) protein using whole cell 
extracts from cortical neurons (4-6DIV) that have been nucleofected with the indicated 
shRNA expression vectors. Migration of the Nova1-specific band is marked by an 
arrowhead. ß-Actin was used as a loading control. C-E) Reporter gene assay 
performed in either rat hippocampal neurons (14DIV, C) or cortical neurons (14DIV, D, 
E) that have been transfected with pGL4 vectors carrying the indicated 3’UTR together 
with either control, Nova1 or Ncoa3 shRNA expression vectors 3 days before. Relative 
luciferase activity (RLA) represents the ratio of firefly reporter activity to renilla control 
reporter activity which is normalized to a basal condition without shRNA expression 
vector. Presented are averages ± standard deviations from three independent 
experiments. One-way ANOVA: p<0.0001 (E), p<0.001 (D), p<0.05 (C). Tukey HSD 
test (C) and unpaired student’s t-test (D, E): *p<0.05, **p<0.01.(student’s t-test to 
control shRNA). F, G) Reporter gene assays in cortical neurons (14DIV) were 
performed in principle as described in C-E), instead that GFP expression vectors were 
used. Presented are averages ± standard deviations from three independent 
experiments. unpaired student’s t-test: *p<0.05. 
 
 
 
Figure E4: Validation of Nova1 and Ncoa3 dependent regulation of Limk1. 
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A) Technical replicate of the experiment in Fig. 4A) and the corresponding 
quantification of n=2 in B). C, D) Technical replicates of the experiments in Fig. 4B) and 
the quantification of n=3 in E). *p<0.05 (student’s t-test). 
Figure E5: Validation of Nova1-Ago interaction by co-IP. 
A) This experiment is a biological replicate of Fig. 5A. B) Nova1 band intensities from 
figures 5A and E5A were quantified using ImageJ software. Values are given as 
percent intensity compared to the input signal and represent the average of two 
independent experiments. C, D) Equal experimental setup as in Fig. 5A) and E5A) 
except that RNAse A was added to the lysate before IP.  E) Validation of anti-pan-Nova 
antibody. Western blot analysis using brain lysate from Nova knockout mice. F) 
Western blot analysis in lysates from HEK293 cells transfected with the indicated NHA-
fusion constructs. Upper panel: anti-HA Western Blot; lower panel: anti-ß-Actin 
Western Blot as loading control. * non-identified cross-reactive protein. G) 
Immunocytochemistry in neurons transfected with the indicated NHA-Nova1 
constructs. Upper panel: anti-HA. Middle panel: Hoechst (nuclei); lower panel: MAP2 
(dendrites). H) Tethering assay in HEK293 cells with the indicated expression 
constructs as in Fig. 5D-F. Presented are averages ± standard deviations from three 
independent experiments. One-way ANOVA: p<0.001. Tukey HSD test: *p<0.05, 
**p<0.01, ns= not significant. 
Figure E6: Dendritic outgrowth after Nova1 knock-down and validation of Ncoa3 
and Drosha shRNA efficacy.  
A) Dendritic outgrowth of cultured hippocampal neurons was analyzed by Sholl’s 
method after transfection with GFP and Nova1 shRNA, control shRNA expression 
vector, or no additional vector as in Fig. 6. B) Summation of the intersection number 
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over all analyzed distances from the data in A). C) Western blot analysis of GFP-Ncoa3 
in cell extracts from HEK293 cells that had been transfected with indicated shRNA 
constructs together with GFP-Ncoa3 expression vectors. Expression of co-transfected 
GFP was used as a loading control. Note that GFP-Ncoa3R is not resistant to Ncoa3 
shRNA#1, but to shRNA#2 which is used for all experiments in the main body. D) 
Western blot analysis of Drosha in hippocampal neurons (19DIV) that had been 
infected with rAAV expressing the indicated shRNAs after 12DIV. ß-Actin was used as 
a loading control. E) qPCR analysis of indicated mRNAs in rAAV-Drosha or control 
shRNA infected neurons. Values are normalized to the rAAV control shRNA condition 
for each target mRNA. N=3. F) Taqman qPCR analysis of indicated mature miRNAs in 
rAAV-Drosha or control shRNA infected neurons. Values are normalized to the rAAV 
control shRNA condition for each target mRNA. N=2. 
Figure E7: Figure 7 does not have an expanded view. 
Figure E8: rAAV-infection efficacy, microarray validation and additional Ncoa3-
ChIP experiments. 
A) Immunocytochemistry in hippocampal neurons (14DIV) that had been infected with 
rAAV expressing the indicated shRNAs after 4DIV. MAP2 staining (red) was used to 
visualize neurons, Hoechst (blue) to visualize cell nuclei. Co-expression of GFP from 
rAAV vectors in MAP2-positive cells was used to determine transfection efficiency with 
approx. 80% from 3 independent infections (approx. 80%). Scale bar = 100 µm. B) 
Matrix of Pearson’s correlation coefficients of signals obtained from 6 independent 
microarray hybridizations. C) qPCR analysis of indicated mRNAs in hippocampal 
neurons (14DIV) that had been infected with rAAV for the expression of indicated 
shRNAs at 4DIV. mRNA levels were normalized to GAPDH and a non-infected basal 
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condition was set to 1. Presented are averages ± standard deviations from three 
independent infections. **p<0.01 (unpaired student’s t-test). D) Quantification of Ago2 
protein levels in hippocampal neurons from three independent Western Blots 
performed as in Fig. 8D. Band densities were normalized to -Tubulin and a non-
infected condition (basal) was set as 1. Presented are averages ± standard deviations. 
*p<0.05 (unpaired student’s t-test). E, F) qPCR analysis of indicated Ncoa3-regulated 
transcripts from two additional Ncoa3-ChIP experiments performed in either control 
shRNA (black) or Ncoa3 shRNA (grey) infected neurons. Values are presented as 
fraction of the respective input DNA used for ChIP. As a specificity control, ChIP with 
an unrelated IgG was performed in control shRNA transfected neurons (white). G) 
Alignment of mouse, rat and human Ago2 promoter sequences for the construction of 
the Ago2 luciferase promoter reporter used in Fig. 8F. The putative RXRA binding site 
is depicted in bold. Non-conserved nucleotides are shown in italics.  
Figure E9: Validation of Flag/HA-Ago2 expression in hippocampal neurons and 
HEK293 cells. 
A) Left panel: Immunocytochemistry using anti-HA antibody (red) in hippocampal 
neurons (14DIV) that had been transfected with either Flag/HA-Ago2 (top) or an empty 
Flag/HA plasmid (control vector, bottom) three days before. Co-transfection of GFP 
(green) was used to outline neuronal morphology. Hoechst counterstain (blue) was 
used to visualize nuclei. Scale bar = 40 m. Right panel: Higher magnification of the 
neurons shown on the left, illustrating the predominant cytoplasmic localization of 
Flag/HA-Ago2. Scale bar = 15 m. B) Western blot analysis of Flag/HA-Ago2 using 
anti-Flag antibody in cell extracts from HEK293 cells that had been transfected with 
Flag/HA-Ago2 or empty Flag/HA plasmid (control vector). -Tubulin was used as a 
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loading control. C) Immunocytochemistry using anti-Ago2 antibody (upper panel) in 
hippocampal neurons (12DIV) treated as described in Fig. 9A. Co-transfection of GFP 
(green, lower panel) served to outline the neuronal soma and was used for 
quantification of the signal. Scale bar = 10 m.  
Extended dataset 1: List of all siRNAs used for in initial screen. 
Extended dataset 2: Results of the initial screen. 
Extended dataset 3: Complete list of genes altered by rAAV-Ncoa3 shRNA 
(Fc>1.3, p<0.05) including non-annotated transcripts. 
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6. Appendix 
6.1 List of abbreviations 
3’ UTR   3’ untranslated region 
AAV   Adeno-associated virus 
Ago   Argonaute protein 
APT1    acyl-protein thioesterase 1 
AMPA   α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AMPA-R  AMPA-receptor  
BDNF   brain-derived neurotrophic factor 
CACNA1C  voltage-dependent L-type calcium channel subunit alpha-1C 
CAT-1   cationic amino acid transporter 1 
ChIP   chromatin immunoprecipitation 
CLIP    cross-linking immunoprecipitation 
CREB1  cyclic AMP-responsive element-binding protein 1 
CSMD1  CUB and sushi domain-containing protein 1 
DGCR8  DiGeorge syndrome critical region 8 
DHPG   Dihydroxyphenylglycine 
DIV   days in vitro 
DNA   deoxyribonucleic acid 
Drd2   dopamine-receptor 2 
eIF4E-BP2  eukaryotic initiation factor 4E binding protein 2 
Fig.   figure 
FMRP   fragile X mental retardation protein  
GFP   green fluorescent protein 
GluA1   ionotropic glutamate receptor, AMPA-selective 1 
GluA2   ionotropic glutamate receptor, AMPA-selective 2 
GW182  glycine-tryptophan protein of 182 kDa  
HMGA2  high mobility group AT-hook protein 2 
Limk1   LIM-domain kinase 1 
Lin-41   abnormal cell lineage 41 
LTD   long-term depression 
MAP 9   microtubule-associated protein 9 
List of abbreviations 
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mEPSC  miniature excitatory postsynaptic current 
mGluR  metabotropic glutamate receptor 
Mib1   mind bomb homolog 1 
miRISC  microRNA-induced silencing complex 
miRNA  microRNA 
Mov10  Moloney leukemia virus 10 
mRNA  messenger RNA 
Ncoa3   nuclear receptor co-activator 3 
NMDA  N-methyl-D-aspartate 
NMDA-R  NMDA-receptor 
Nova1   neuro-oncological ventral antigen 1 
pLNA   power locked nucleic acids 
PND   post-natal day 
pre-miRNA  precursor microRNA 
pri-miRNA  primary microRNA 
Pub.   publication 
Pum2   Pumilio2 
qPCR   quantitative PCR 
RBP   RNA-binding protein 
RNA   ribonucleic acid 
RNAi   RNA interference 
shRNA  short hairpin RNA 
siRNA   small interfering RNA 
TCF4   transcription factor 4 
TNF-alpha  tumor necrosis factor alpha 
Tnrc6   trinucleotide repeat-containing gene 6 
TRBP   trans-activation-responsive RNA-binding protein 
UHMK1  U2AF homology motif kinase 1 
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